GMTEight List of A-share restricted sales and lifting restrictions | November 24th
Sorry, please provide the text you would like translated into English.
On November 24th, a total of 14 listed companies had their restricted shares lifted, with a total market value of approximately 5.256 billion yuan.
The specific situation of the restricted shares being lifted today is as follows:
Stock Abbreviation Stock Code Restricted Share Type Number of Shares Unrestricted
Hubei Energy Group000883Equity Incentive Restricted Shares31.47 million
Asia-Potash International Investment000893Equity Incentive Restricted Shares2.4 million
China Southern Airlines600029Additional A Shares distributed to original shareholders at IPO8.04 billion
Ningbo Yunsheng600366Additional A Shares distributed to legal persons at IPO35.99 million
Hualan Biological Engineering, Inc.002007Equity Incentive Restricted Shares1.3243 million
Beijing Join-cheer Software002279Equity Incentive Restricted Shares2.4478 million
Gifore Agricultural Science & Technology Service300022Equity Incentive Restricted Shares250,000
Haimo Technologies Group Corp.300084Equity Incentive Restricted Shares270.9 million
Anhui Jinhe Industrial002597Equity Incentive Restricted Shares546,400
Well Lead Medical603309Equity Incentive Restricted Shares33,000
Amoy Diagnostics300685Equity Incentive Restricted Shares1.5363 million
Hichain Logistics300873Additional A Shares distributed to original shareholders at IPO17.2684 million
Xianheng International Science & Technology605056Equity Incentive Restricted Shares318.9 million
Hangzhou Haoyue Personal Care605009Equity Incentive Restricted Shares32.4 million
Related Articles

HK Stock Market Move | Jiangsu Hengrui Pharmaceuticals (01276) rose more than 5%, and 9 drugs including SHR-9839 for injection were approved for clinical trials.

HK Stock Market Move | MIRXES-B (02629) rose nearly 8% in the early session, working together with Watson to develop the ASEAN market, and jointly building an innovative RNA precision medical system.
.png)
China Postal Securities: PROTAC achieves "0-1" breakthrough, optimistic about the potential of self-immunity oral breakthrough.
HK Stock Market Move | Jiangsu Hengrui Pharmaceuticals (01276) rose more than 5%, and 9 drugs including SHR-9839 for injection were approved for clinical trials.

HK Stock Market Move | MIRXES-B (02629) rose nearly 8% in the early session, working together with Watson to develop the ASEAN market, and jointly building an innovative RNA precision medical system.

China Postal Securities: PROTAC achieves "0-1" breakthrough, optimistic about the potential of self-immunity oral breakthrough.
.png)





